TCR2 Therapeutics Review: biotech against oncological diseases
TCR2 Therapeutics IncTCRR2,35 $ TCR2 Therapeutics (Nasdaq: TCRR) is an American biotechnology company from Massachusetts, which develops new methods of immunotherapy and appropriate drugs for patients with oncology.